Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma. 1994

H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
Department of Dermatology, Faculty of Medicine, University of Tokyo, Japan.

BACKGROUND Intercellular adhesion molecule-1 (ICAM-1) is important in immune-mediated mechanisms, and its circulating form (cICAM-1) may be an indicator of immune activation. Localized scleroderma is accompanied by various immunologic abnormalities. OBJECTIVE We investigated whether the serum level of cICAM-1 in patients with localized scleroderma was elevated and was correlated with the clinical or serologic features of this disease. METHODS Serum cICAM-1 levels were determined by an enzyme-linked immunosorbent assay in 48 patients with localized scleroderma, in 20 patients with systemic sclerosis, and in 20 healthy control subjects. RESULTS Serum levels of cICAM-1 were significantly higher in patients with localized scleroderma than in the healthy control subjects. These levels correlated with the number of lesions, the number of involved areas, levels of antihistone antibody IgM, and levels of soluble interleukin 2 receptor. CONCLUSIONS The results suggest that immune activation may be a factor in localized scleroderma.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D004277 DNA, Single-Stranded A single chain of deoxyribonucleotides that occurs in some bacteria and viruses. It usually exists as a covalently closed circle. Single-Stranded DNA,DNA, Single Stranded,Single Stranded DNA
D005260 Female Females
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D012217 Rheumatoid Factor Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS. Factor, Rheumatoid

Related Publications

H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
January 1994, Clinical and experimental rheumatology,
H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
January 1996, Cardiology,
H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
June 1992, Arthritis and rheumatism,
H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
August 1993, Arthritis and rheumatism,
H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
January 2002, Rheumatology international,
H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
April 1995, British journal of rheumatology,
H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
January 1997, Anticancer research,
H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
December 1990, Arthritis and rheumatism,
H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
December 1992, International journal of hematology,
H Ihn, and M Fujimoto, and S Sato, and K Kikuchi, and A Igarashi, and Y Soma, and K Takehara
April 1993, Journal of neuroimmunology,
Copied contents to your clipboard!